09 Dec 2011 04:12:03
Biodiesel opportunities for Aeternum
Aeternum, the specialist UK infrastructure developers, have begun successfully producing commercial biodiesel at their facility in Bromborough, near Liverpool. The announcement follows a £12m investment in the plant that will enable the production of approximately 130,000 tonnes of biodiesel over the next two years.
Aeternum's feedstock procurement specialists have finalised supply contracts for rapeseed oil, a key ingredient in biodiesel. The firm's current feedstock programme, which is supplied by European farmers, allows Aeternum to secure rapeseed oil at structured discounts to the spot market over the medium term, working alongside its specialist commodity partners. There is also exciting potential for the firm to engage with further production partners, as the plant is currently running at approximately 50% of its capacity.
Aeternum has worked with industry specialists to verify the sustainability criteria for all of its feedstock. With the aim of having a transparent carbon footprint, the company is currently undertaking a detailed life cycle analysis as part of its long term biofuels lobbying programme, in order to secure equal treatment between its feedstock and used cooking oil equivalents.
David Frohnsdorff, partner at Aeternum, said:
“We are delighted to be starting the production of commercial biodiesel, which is one of several exciting renewable energy projects we are working on.
“The increasing use of biodiesel in engines will help the UK to reduce its dependence on carbon intensive fuel sources and to meet its stringent renewable energy targets.
“An increase in production is good news for UK biodiesel consumers. By investing in cutting edge technology, we have been able to increase our output at a time when many biodiesel producers have ceased production due to difficult market conditions.
“Only by adopting alternative energy sources, such as biodiesel, will the UK be able to successfully make the transition to a low carbon economy.”
For further enquiries please contact the Aeternum press office.